Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

The evERA breast cancer trial marks a turning point for some patients with a specific type of advanced breast cancer known as ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Metastatic breast cancer treatment with the combination of PCS6422 and capecitabine (NGC-Cap) may increase the cancer-killing ...

King Faisal Specialist Hospital & Research Centre has embedded palliative care as a core component of its oncology services, recognizing its role in addressing the complex physical, psychological, and ...

Dr. Ariel Ostad sat down with CURE to discuss the often-overlooked emotional and practical challenges that patients face ...